← Eichor
Study identifier: NCT07531966 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vascular Complications After Kidney Transplantation

Condition: Kidney Transplant Recipient · Kidney Transplant; Complications · Transplant Renal Artery Stenosis  ·  Sponsor: University of Aarhus

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

* To determine the incidence of arterial inflow problems and venous outflow problems as causes of impaired renal function and/or treatment-resistant hypertension after kidney transplantation, when all kidney-transplant recipients in Denmark are evaluated according to uniform, well-defined clinical criteria. * To investigate the efficacy and safety of catheter-based balloon treatment (percutaneous transluminal angioplasty, PTA) for these vascular complications, of which transplant renal artery stenosis is by far the most common. * To assess whether novel imaging and functional diagnostic methods can predict treatment response.

This description comes directly from the study's public registry record.

Talk to the study team

Mark Reinhard, MD, PhD  ·  +45 40460321  ·  markrein@rm.dk

Henrik Birn, MD, DMSc  ·  hb@clin.au.dk

Always discuss trial participation with your own doctor first.

Locations (3)

Aarhus University HospitalAarhus, DenmarkRecruiting
RigshospitaletCopenhagen, DenmarkRecruiting
Odense University HospitalOdense, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07531966